Codexis

CDXS · NASDAQ

$1.23−$0.09 (−6.82%)TodayMarket closed ·
Prev close $1.32

Latest news

  • Press releaseGlobe Newswire

    Codexis Reports Second Quarter 2026 Financial Results

  • News

    12 Health Care Stocks Moving In Friday's Intraday Session

  • NewsAvi Kapoor

    Crude Oil Down Over 4%; Verizon Raises Earnings Forecast

  • NewsAvi Kapoor

    US Stocks Mixed; American Express Shares Fall Following Q2 Results

  • News

    12 Health Care Stocks Moving In Friday's Pre-Market Session

  • NewsTanya Rawat

    Why Codexis Stock Is Falling After Hours Today

  • News

    12 Health Care Stocks Moving In Thursday's After-Market Session

  • News

    12 Health Care Stocks Moving In Thursday's After-Market Session

  • Press releaseGlobe Newswire

    Codexis Reports First Quarter 2026 Financial Results

  • News

    Codexis To Present New Data And Provide Regulatory Update On ECO Synthesis Manufacturing Platform At TIDES USA May 11-14

  • Press releaseGlobe Newswire

    Codexis to share RNA manufacturing advances at TIDES USA

  • News

    12 Health Care Stocks Moving In Thursday's Intraday Session

  • NewsAvi Kapoor

    Crude Oil Surges Over 8%; Dollar General Shares Fall After Q4 Results

  • NewsAvi Kapoor

    Dow Tumbles Over 1%; US Weekly Jobless Claims Fall

  • News

    12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • Press releaseGlobe Newswire

    Codexis Reports Fourth Quarter and Fiscal Year 2025 Financial Results

  • News

    Preview: Codexis's Earnings

  • Press releasePRNewswire

    Codexis signs agreement to manufacture 50 g siRNA using its ECO Synthesis® Manufacturing Platform

  • Press releasePRNewswire

    Codexis Expands Reach of the ECO Synthesis® Manufacturing Platform through a Signed Evaluation Agreement with Axolabs for Oligonucleotide Therapeutics

  • News

    12 Health Care Stocks Moving In Friday's After-Market Session

  • News

    12 Health Care Stocks Moving In Friday's Pre-Market Session

  • News

    Earnings Scheduled For November 6, 2025

  • Press releasePRNewswire

    Codexis and Nitto Denko Avecia Enter Evaluation Agreement to Explore Codexis's ECO Synthesis® Manufacturing Platform for Therapeutic siRNA Manufacturing

  • News

    12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • News

    12 Health Care Stocks Moving In Wednesday's After-Market Session

  • News

    12 Health Care Stocks Moving In Wednesday's Pre-Market Session

  • News

    A Look at Codexis's Upcoming Earnings Report

  • News

    12 Health Care Stocks Moving In Wednesday's After-Market Session

  • Press releaseGlobe Newswire

    Codexis Reports Fourth Quarter and Fiscal Year 2024 Financial Results

  • News

    Deep Dive Into Codexis Stock: Analyst Perspectives (4 Ratings)

  • Press releaseGlobe Newswire

    Codexis Announces Appointment of Raymond De Vré, PhD, to Board of Directors

  • Press releaseGlobe Newswire

    Codexis Reports Third Quarter 2024 Financial Results

  • Press releaseGlobe Newswire

    Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors

  • Press releaseGlobe Newswire

    Codexis Increases Cash Reserves and Enhances Management Team to Fuel Growth of Company

  • Press releaseGlobe Newswire

    Codexis Reports Second Quarter 2024 Financial Results

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.